The sell-off in Humana is overdone after strong earnings. Jim Cramer says buy the stock
Investors are getting an opportunity to add to their positions in the Medicare Advantage-focused health insurer.
UsenB
0
43
In this photo illustration, Humana Inc. logo seen displayed on a tablet.
Getty Images
The post-earnings decline in Humana (HUM) shares Wednesday was overdone, providing investors an opportunity to add to their positions in the Medicare Advantage-focused health insurer.
The Club holding remains on solid ground after delivering a top- and bottom-line beat in the third quarter.
